Guest Editor(s)
-
- Daniele Santi, MD, PhD
- Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria of Modena, Ospedale Civile of Baggiovara, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy.
Website | E-mail
-
- Angelo Cignarelli, MD, PhD
- Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Italy.
Website | E-mail
Special Issue Introduction
Hypogonadism identifies a clinical condition characterized by the impairment of gonadal function in both sexes, generally due to a partial or total breakdown of the cross-communication between and/or within the hypothalamus, pituitary and gonads. Hypogonadism is largely suspected to be related to several systemic diseases. Whether the systemic illnesses cause real hypogonadism or whether the find of gonadal dysfunction represents an epiphenomenon of the primary systemic disease remains far to be completely elucidated.
This special issue is designed to highlight the relationship between the most common chronic systemic diseases and hypogonadism in both males and females. Following topics will be discussed in this issue:
● Hypogonadism in NAFLD
● Hypogonadism in chronic kidney disease
● Hypogonadism in chronic hypoxia
● Hypogonadism in iron overload disease
● Hypogonadism in diabetes mellitus
● Hypogonadism in overweight and obesity
● Hypogonadism in cardiovascular diseases
etc.
Participants
1. Elena Armeni, 2nd Department of Obstetrics and Gynecology, University of Athens, Aretaieio Hospital, Athens, Greece.
2. Greco Carla, Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
3. Angelo Di Vincenzo, Clinica Medica 3, Department of Medicine - DIMED, University-Hospital of Padova, Padova, Italy.
4. Mojdeh Fathi, Department of Nutrition, Faculty of Paramedicine, Ahvaz Jundishapur, University of Medical Sciences, Ahvaz, Iran.
5. Dimitrios Goulis, Unit of Reproductive Endocrinology, 1St Department of Obstetrics and Gynecology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
6. Abiodun J. Kareem, Department of Pediatrics and Child Health, Obafemi Awolowo University, Ile-Ife, Nigeria.
7. Ljiljana Marina, Department for Obesity, Reproductive and Metabolic Disorders, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
8. Farid Saad, Dresden International University, Center of Medicine and Health Sciences, Dresden, Germany.
9. Svetlana Vujović, Department for Obesity, Reproductive and Metabolic Disorders, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
10. Yasin Yilmaz, Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Institute of Health Sciences, Istanbul, Turkey.
11. Lello Zolla, Department of Biological and Ecological Sciences DEB, Tuscia University, Viterbo, Italy.
Submission Deadline
31 Jan 2023
Metabolism and Target Organ Damage
